Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Net Income (2019 - 2025)

Historic Net Income for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $399.7 million.

  • CureVac's Net Income fell 970.36% to $399.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.5 million, marking a year-over-year increase of 3952.32%. This contributed to the annual value of $173.3 million for FY2024, which is 16191.36% up from last year.
  • Latest data reveals that CureVac reported Net Income of $399.7 million as of Q3 2025, which was down 970.36% from -$68.3 million recorded in Q2 2025.
  • CureVac's 5-year Net Income high stood at $442.7 million for Q3 2024, and its period low was -$183.5 million during Q2 2021.
  • Over the past 5 years, CureVac's median Net Income value was -$68.3 million (recorded in 2025), while the average stood at -$24.3 million.
  • Per our database at Business Quant, CureVac's Net Income tumbled by 196018.44% in 2022 and then surged by 93557.63% in 2024.
  • CureVac's Net Income (Quarter) stood at -$6.4 million in 2021, then plummeted by 1960.18% to -$131.0 million in 2022, then grew by 28.77% to -$93.3 million in 2023, then fell by 16.52% to -$108.7 million in 2024, then surged by 467.64% to $399.7 million in 2025.
  • Its last three reported values are $399.7 million in Q3 2025, -$68.3 million for Q2 2025, and $54.8 million during Q1 2025.